For more than four decades, I’ve navigated the turbulent, rewarding waters of microcap and penny stock investing. A key tool in my kit was never a complex algorithm or a secret formula, but something far more human: the humble online message board. For years, the activity on forums like Stockhouse served as a reliable barometer of retail investor sentiment. A flurry of posts, a spike in views—these were the digital footprints of an engaged investor community, a sign that a company’s story was capturing imaginations and, soon, their capital.
Today, those forums are often ghost towns.
This isn’t just nostalgia. It’s a symptom of a profound shift in the retail investing landscape. Even when a solid small-cap company releases stellar financial results, the reaction can be strangely muted. The buying volume might be half-decent, but the online chatter, the community buzz that once signaled a stock was ready to run, is often non-existent.
So, where did all the retail investors go? They’ve checked into the financial equivalent of a sprawling, all-inclusive resort: the Exchange-Traded Fund (ETF). And this mass migration is having a chilling effect on individual microcap stocks, even the most deserving ones. To understand this phenomenon, look no further than the curious case of cannabis company Cronos Group (CRON).
The Allure of the Easy Button: Why ETFs Are Winning
The growth of ETFs has been called the single most disruptive trend in asset management over the past 20 years. Total assets in U.S.-listed ETFs have ballooned to nearly $9 trillion, with a compound annual growth rate far outpacing traditional mutual funds. In June 2025 alone, the value of US ETF assets stood at $11.49 trillion, a year-over-year increase of over 25%.
For the retail investor, the appeal is undeniable. ETFs offer a simple, one-click solution to several of investing’s biggest challenges.
- Instant Diversification: Why spend hours researching dozens of companies in a sector when you can buy a single share of an ETF and own a piece of all of them? This immediately spreads risk, protecting an investor from the catastrophic failure of a single company.
- Simplicity and Low Effort: The hard work of picking and choosing is done by the fund manager. For investors who don’t have the time or expertise to perform deep due diligence on individual microcap stocks, ETFs are the path of least resistance to earning stock-like returns.
- Lower Costs: ETFs typically feature lower expense ratios and can reduce the brokerage commissions that would rack up from buying dozens of individual stocks.
This combination of convenience and perceived safety has created a powerful gravitational pull, redirecting a massive flow of retail capital away from individual stock picking and into broad, sector-based funds.
Case Study: Cronos Group, a Star Without an Audience
To see the ETF effect in action, consider Cronos Group (CRON $3.10 TSX 08/08/25), a cannabis company listed on both the TSX and NASDAQ. By any traditional measure, Cronos is a standout in a notoriously volatile sector.
The company boasts what its own CEO calls the strongest balance sheet in the industry, with USD $834 million in cash and short-term investments and no debt. Its financial health is rated a perfect 6 out of 6 by some analysts.
On August 8, 2025, the company released very strong second-quarter financials. Revenue grew 21% year-over-year to $33.5 million, beating forecasts. Gross profit surged an incredible 130%, with margins nearly doubling from 23% to 43%. Its popular “Spinach” brand is the second-largest cannabis brand in Canada with various products / brands doing extremely well in Australia, Israel, Switzerland, Germany and the UK.
In the past twenty five years, this kind of news would have sent the Stockhouse message boards into a small feeding frenzy. We would have seen a dramatic increase in posts, analysis, and speculation, driving further interest and likely, a significant surge in buying volume.
The reality on August 8, 2025? The stock price saw a respectable bump, but the retail community was “radio-silent”. There wasn’t a single new post on the Stockhouse Cronos bullboard (Stockhouse is typically the bellwether for Canadian listed penny stock sentiment). The last post was from March 2025. This deafening silence is the sound of the modern retail market.
Investors who want exposure to the cannabis sector are no longer meticulously comparing the balance sheets of Cronos, Tilray, and Canopy Growth. Instead, they’re simply buying a cannabis ETF like the Global X Marijuana Life Sciences Index ETF (HMMJ) on the TSX or the AdvisorShares Pure US Cannabis ETF (MSOS) on the NYSE. Cronos is, in fact, a top holding in HMMJ and other global cannabis funds like the Amplify Alternative Harvest ETF (MJ).
So while Cronos benefits indirectly from these ETF purchases, the direct link between the company’s performance and the retail investor’s action is severed. The capital flows are passive and indiscriminate, lifting all boats in the sector rather than rewarding the most seaworthy vessel.
The Collateral Damage for Microcaps and Penny Stocks
This shift from active stock picking to passive ETF investing creates an existential threat for even the most promising microcap and penny stocks.
- The Audience is Gone: Without a dedicated community of retail investors performing due diligence, good news falls on deaf ears. A brilliant earnings report or a game-changing contract can fail to move the needle because the audience that would normally react and create buying pressure is now just passively holding a sector ETF.
- Liquidity Dries Up: As investment dollars consolidate into a few dozen popular ETFs, the trading volume for thousands of individual small stocks diminishes. This lack of liquidity makes it harder for investors to buy and sell without affecting the stock price, further discouraging investment.
- Discovery is Stifled: ETFs reward the biggest players. Their market-cap-weighted structure means the largest companies in a sector receive the largest share of investment. This makes it incredibly difficult for a small, innovative company to get noticed and attract the capital it needs to grow. They are, in effect, being starved of the oxygen that the retail market once provided.
For the dedicated penny stock investor, the game has changed. The potential for outsized returns by finding an undiscovered gem still exists, but these gems are being left in the dark, overshadowed by the convenience and sheer scale of the ETF industry. The silence on the message boards isn’t just a lack of chatter; it’s a warning sign that the crowd has moved on, and high-quality small companies may be the ones who pay the price.